Back to top
more

Palatin Technologies (PTN)

(Real Time Quote from BATS)

$1.79 USD

1.79
63,996

-0.03 (-1.65%)

Updated Apr 29, 2024 01:42 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value F Growth D Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 30% (76 out of 252)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

Research for PTN

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

0 items in cart

Palatin Technologies, Inc. [PTN]

Reports for Purchase

Showing records 141 - 160 ( 194 total )

Company: Palatin Technologies, Inc.

Industry: Medical - Biomedical and Genetics

Record: 141

05/13/2014

Daily Note

Pages: 3

MID-DAY SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: Palatin Technologies, Inc.

Industry: Medical - Biomedical and Genetics

Record: 142

05/13/2014

Company Report

Pages: 6

F3Q14 Results; Eager Beavers on Partnering Front; Reiterate Buy

Provider: Roth Capital Partners, Inc.

Analyst: PANTGINIS J

Price: 25.00

Research Provided by a Third Party

Company: Palatin Technologies, Inc.

Industry: Medical - Biomedical and Genetics

Record: 143

05/01/2014

Company Report

Pages: 6

We Think Just Inches Away Now; Option Exercised; Reiterate Buy

Provider: Roth Capital Partners, Inc.

Analyst: PANTGINIS J

Price: 25.00

Research Provided by a Third Party

Company: Palatin Technologies, Inc.

Industry: Medical - Biomedical and Genetics

Record: 144

05/01/2014

Daily Note

Pages: 4

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: Palatin Technologies, Inc.

Industry: Medical - Biomedical and Genetics

Record: 145

04/01/2014

Daily Note

Pages: 3

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: Palatin Technologies, Inc.

Industry: Medical - Biomedical and Genetics

Record: 146

04/01/2014

Company Report

Pages: 6

Delayed Gratification; Another Cool Million for Your Time; Reiterate Buy

Provider: Roth Capital Partners, Inc.

Analyst: PANTGINIS J

Price: 25.00

Research Provided by a Third Party

Company: Palatin Technologies, Inc.

Industry: Medical - Biomedical and Genetics

Record: 147

03/21/2014

Daily Note

Pages: 3

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: Palatin Technologies, Inc.

Industry: Medical - Biomedical and Genetics

Record: 148

03/21/2014

Company Report

Pages: 14

The Sleeper Shall Awaken; Are You Ready?

Provider: Roth Capital Partners, Inc.

Analyst: PANTGINIS J

Price: 50.00

Research Provided by a Third Party

Company: Palatin Technologies, Inc.

Industry: Medical - Biomedical and Genetics

Record: 149

02/25/2014

Daily Note

Pages: 3

MID-DAY SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: Palatin Technologies, Inc.

Industry: Medical - Biomedical and Genetics

Record: 150

02/25/2014

Daily Note

Pages: 3

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: Palatin Technologies, Inc.

Industry: Medical - Biomedical and Genetics

Record: 151

02/24/2014

Company Report

Pages: 7

F2Q14 Results; New Positive Data from Phase IIb BMT Study; Reiterate Buy

Provider: Roth Capital Partners, Inc.

Analyst: PANTGINIS J

Price: 25.00

Research Provided by a Third Party

Company: Palatin Technologies, Inc.

Industry: Medical - Biomedical and Genetics

Record: 152

02/12/2014

Daily Note

Pages: 3

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: Palatin Technologies, Inc.

Industry: Medical - Biomedical and Genetics

Record: 153

02/12/2014

Company Report

Pages: 6

Flibanserin Visibility Helps BMT''s Differentiation; Reiterate Buy

Provider: Roth Capital Partners, Inc.

Analyst: PANTGINIS J

Price: 25.00

Research Provided by a Third Party

Company: Palatin Technologies, Inc.

Industry: Medical - Biomedical and Genetics

Record: 154

01/08/2014

Industry Report

Pages: 21

Partnering Watch in High Gear; What We are Looking/Hoping For

Provider: Roth Capital Partners, Inc.

Analyst: PANTGINIS J

Price: 75.00

Research Provided by a Third Party

Company: Palatin Technologies, Inc.

Industry: Medical - Biomedical and Genetics

Record: 155

11/21/2013

Daily Note

Pages: 3

MORNING CALL SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: Palatin Technologies, Inc.

Industry: Medical - Biomedical and Genetics

Record: 156

11/21/2013

Company Report

Pages: 7

Things Are Heating Up....Are You In? We Are! Reiterate Buy

Provider: Roth Capital Partners, Inc.

Analyst: PANTGINIS J

Price: 25.00

Research Provided by a Third Party

Company: Palatin Technologies, Inc.

Industry: Medical - Biomedical and Genetics

Record: 157

11/14/2013

Daily Note

Pages: 2

MID-DAY SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: Palatin Technologies, Inc.

Industry: Medical - Biomedical and Genetics

Record: 158

11/14/2013

Company Report

Pages: 6

F1Q14 Results; Crunch Time; Pointing in Right Direction for Partners

Provider: Roth Capital Partners, Inc.

Analyst: PANTGINIS J

Price: 25.00

Research Provided by a Third Party

Company: Palatin Technologies, Inc.

Industry: Medical - Biomedical and Genetics

Record: 159

10/28/2013

Daily Note

Pages: 3

MID-DAY SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: Palatin Technologies, Inc.

Industry: Medical - Biomedical and Genetics

Record: 160

10/28/2013

Daily Note

Pages: 4

Bioequivalence Study Done; Bring On the Phase III and Partner

Provider: Roth Capital Partners, Inc.

Analyst: PANTGINIS J

Price: 10.00

Research Provided by a Third Party